• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1998 Fiscal Year Final Research Report Summary

Elucidation of genetic abnormality and molecular pathogenesis of hereditary hemorrhagic telangiectasia

Research Project

Project/Area Number 09671117
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionUniversity of Tokushima

Principal Investigator

AZUMA Hiroyuki  University of Tokushima, University Hospital, Assistant Professor, 医学部附属病院, 講師 (10241275)

Co-Investigator(Kenkyū-buntansha) AKAIKE Masashi  University of Tokushima, University Hospital, Research Associate, 医学部附属病院, 助手 (90271080)
Project Period (FY) 1997 – 1998
KeywordsHHT / TGF-beta / Endoglin / Smad
Research Abstract

Hereditary hemorrhagic telangiectasia(HHT) is an autosomal dominant disorder characterized by peripheral vascular dysplasia and recurrent hemorrhage from those lesions. Recent investigation has mapped one of the responsible genes for HHT to chromosome 9q33-q34 ; subsequently, nine different mutations have been identified in the endoglin gene, which encodes a transforming growth factor beta (TGF- beta) binding protein. We found a Japanese HHT family and identified a C to A mutation in exon 4 which changed an Ala^<160> codon(GCT) to an Asp^<160> codon(GAT). In order to reveal the mechanism by which vascular dysplasia was elicited in patients with having this mutation, TGF- beta signaling function was analyzed using recombinant normal and mutant endoglin proteins expressed in MCF7 cells. We confirmed that both normal and mutant endoglins were expressed on surface membranes of COS-1 cells at similar degrees by immunocytochemistry. Stable cell lines expressing normal or mutant endoglin were also established in MCF7 cells. When TGF- beta was added to these stable transformants, which were previously transfected with Smad2-flag plasmid, nuclear translocation of Smad2-flag protein was detected by immunofluoresense analysis in MCF7 cells expressing normal endoglin. Whereas, no immunofluoresense signal was observed in MCF7 cells expressing mutant endoglin. These results indicated several posibilities that mutant endoglin (1) lacks the binding actibity with TGF- beta, (2) can not present TGF- beta to type II receptor of TGF- beta or (3) fails to assemble to homodimer structure. These analyses are being undertaken now.

  • Research Products

    (4 results)

All Other

All Publications (4 results)

  • [Publications] Yamaguchi H.et al: "A novel missense mutation in the endoglin gene in hereditary hemorrhagic telangiectasia" Thromb.Haewost.77. 243-247 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山口普史 外: "遺伝性出血性末梢血管拡張症の成因" 実験医学. 16. 38-44 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamaguchi H.et al: "A novel missense mutation in the endoglin gene in hereditary hemorrhagic telangiectasia" Thromb. Haemost. 77 (2). 243-247 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamaguchi H.et al: "Pathogenesis of hereditary hemorrhagic telangiectasia" Experimental Medicine. 16. 38-44 (1998)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-12-08  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi